Paragon Care Limited (ASX: PGC) - ETF Exposure

- Current share price for PGC : $0.135

Paragon Care Limited (PGC) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a provider durable medical equipment, medical devices, consumable medical products, and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia, New Zealand and Asia, as well as the distribution of pharmaceuticals, medical consumables, and complementary medicines to the Australian healthcare market.

PGC General Information ⁺

ASX Code	PGC
Website	http://paragoncare.com.au
Industry/Sector	Health Care Distributors
Market Cap ($M)	223
PGC Share Price	$0.135
Day High	$0.135
Day Low	$0.130
Last Close	$0.135
PGC Share Price Movement	- ( No change )

Prices as at 13:35, 11 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to PGC

Paragon Care Limited (PGC) is held across 1 ETF spanning strategies that include health care distributors exposure . Its weighting in those funds means performance can have an outsized influence - when PGC moves, funds like DACE that hold it can move with it.

For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to PGC , while the average exposure across all 1 ETF that hold it is around 0% .

Top ETF holdings

Dimensional Australian Core Equity (Managed Fund) (DACE) ~ 0%

Last updated: ETF data and holdings as at 10 August 2026

Own PGC directly or through an ETF?

How does holding Paragon Care Limited (PGC) shares directly compare to ETFs that include it?

	PGC Direct	DACE ASX
Holdings	1 company	470 holdings
PGC Weight	100%	0%
Diversification	Single Stock	Broad
Annual Cost	Brokerage only	0.28% p.a.
Approx. Yield	-	2.92%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not PGC's direct yield. Annual cost uses each ETF's MER.

PGC Exposure on $10,000 investment

How a $10,000 investment in Paragon Care Limited (PGC) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Paragon Care Limited (PGC)	Direct share	$0.135	8%	+$800	$10,800
Dimensional Australian Core Equity (Managed Fund) (DACE)	Equity - Australia Strategy	$19.560	4.15%	+$415	$10,415

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Paragon Care Limited (PGC) ETFs

1 ETF hold Paragon Care Limited (PGC).

ETF	PGC Weight	MER	Yield
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	2.92%

Paragon Care Limited (PGC) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	0.6¢	100%	18 Sep 2023	6 Oct 2023	-	-	-
Result	0.6¢	100%	14 Mar 2023	5 Apr 2023	-	-	-
HFResult	0.6¢	100%	12 Sep 2022	4 Oct 2022	-	-	-

See all dividends from Paragon Care Limited (PGC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Paragon Care Limited (PGC) price-sensitive announcements

PGC - Infinity Group Recovery and Earnings Update

Paragon Care Limited has provided an update on its financial exposure to the Infinity Reta

Paragon Care Limited (PGC)
1 Jun 2026 | 8:29 AM

PGC - 1H26 Investor Presentation

Paragon Care Limited reported its FY26 half-year financial results, revealing a 2.9% incre

Paragon Care Limited (PGC)
25 Feb 2026 | 9:02 AM

PGC - 1H26 Results Release

Paragon Care Limited, a leading healthcare provider in the Asia Pacific region, announced

Paragon Care Limited (PGC)
25 Feb 2026 | 9:01 AM

PGC - 1H26 Appendix 4D and Half Year Report

Paragon Care Limited's Half Year Report for the period ending 31 December 2025 reveals a c

Paragon Care Limited (PGC)
25 Feb 2026 | 9:00 AM

Paragon Care Limited (PGC) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Paragon Care Limited (PGC) ORDINARY FULLY PAID	Health Care	$223	FY26 Results Briefing	7 Aug 2026 8:42AM	$0.130	$0.135	risen by 3.85%
Paragon Care Limited (PGC) ORDINARY FULLY PAID	Health Care	$223	Change of Director's Interest Notice	3 Jul 2026 9:56AM	$0.160	$0.135	fallen by 15.63%
Paragon Care Limited (PGC) ORDINARY FULLY PAID	Health Care	$223	Notification regarding unquoted securities - PGC	3 Jul 2026 9:55AM	$0.160	$0.135	fallen by 15.63%
Paragon Care Limited (PGC) ORDINARY FULLY PAID	Health Care	$223	Change of Director's Interest Notice	1 Jul 2026 12:49PM	$0.150	$0.135	fallen by 10%
Paragon Care Limited (PGC) ORDINARY FULLY PAID	Health Care	$223	Change of Director's Interest Notice	29 Jun 2026 5:01PM	$0.130	$0.135	risen by 3.85%
Paragon Care Limited (PGC) ORDINARY FULLY PAID	Health Care	$223	Ceasing to be a substantial holder	3 Jun 2026 8:20AM	$0.155	$0.135	fallen by 12.90%

PGC Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2025A	$27.31	$1.70	83.30%	27.10	0.00	0.00%	0.0%
2024A	$8.38	$0.90	-56.50%	27.80	0.00	0.00%	0.0%
2023A	$16.61	$2.10	4.00%	14.70	1.20	3.90%	100.0%

PGC Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
EBOS Group Limited (EBO)	$3,800M	-0.1796	-0.1013	0.1128	14.8172	16.4871	14.8160	5.90%	4.24%	4.72%
Paragon Care Limited (PGC)	$215M	0.8333	0.0000	0.0000	7.8788	0.0000	0.0000	0.00%	0.00%	0.00%
Sigma Healthcare Limited (SIG)	$34,400M	15.7941	0.0893	0.1688	52.1891	47.9100	40.9904	0.60%	1.09%	1.43%

PGC Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.20	8.18	0.68	0.00
Market	0.31	13.10	1.15	0.69
Sector	0.73	19.20	1.65	1.92

PGC Directors

Name	Position	Start Date
Mr David Keith Collins	Chief Executive Officer, Managing Director	3 Jun 2024
Ms Carmen Rose Riley	Chief Operating Officer, Executive Director	3 Jun 2024
Mr Michael Sapountzis	Company Secretary	22 Nov 2024
Mr Peter Andre Lacaze	Non-Executive Chairman, Non-Executive Director	3 Jun 2024
Mr Peter John Egglestone	Non-Executive Director	20 Mar 2025

Paragon Care Limited (PGC) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
30 Jun 2026	WALSTAB, John	Sell	Direct Shares	6,000,000	$0.130	$780,000.000
30 Jun 2026	WALSTAB, John	Buy	Indirect Shares	6,000,000	$0.130	$780,000.000
29 Jun 2026	EGGLESTONE, Peter	Buy	Indirect Shares	200,000	$0.135	$26,980.000

See all changes in directors' interest & trades for Paragon Care Limited (PGC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

PGC Management

Name	Position
Marcus Crowe	Chief Financial Officer

PGC Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Paragon Care Limited (PGC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
471,762,036 (28.50%)	Peter Andre Lacaze
471,762,036 (28.50%)	David Keith Collins
144,591,185 (8.73%)	John Walstab
123,355,662 (7.45%)	Wilson Asset Management Group

PGC Calendar of Events

Date	Event
24 February 2027	Report (Interim)
29 September 2026	Report (Annual)
29 September 2026	Report (Prelim)
26 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us